The FEAD points to prevention and early diagnosis as the pillars for combating pancreatic cancer

The FEAD insists on reducing risks and detecting pancreatic cancer early in order to improve its approach and increase treatment options.

3 minutes

fotonoticia 20261119151048 1920
Add DEMÓCRATA to Google

Published

3 minutes

The Spanish Digestive Apparatus Foundation (FEAD) has emphasized the importance of reducing risk factors and strengthening early diagnosis to reinforce the prevention and management of pancreatic cancer.

Coinciding with World Pancreatic Cancer Day, which is observed on November 19, the FEAD aims to raise public awareness about the need to act on modifiable risk factors, identify people with a higher predisposition to develop this condition, and facilitate its detection in initial stages.

Pancreatic cancer is a relatively uncommon tumor, but it represents one of the greatest challenges among digestive cancers due to its high mortality and the difficulty of identifying it in early stages. In Spain, it is estimated that in 2026 10,405 new cases will be diagnosed.

According to the foundation, despite advances in knowledge about this tumor, the prognosis remains unfavorable, with a net five-year survival rate close to 5 percent in Spain. One of the main causes is that it is often detected when it is already advanced, a time when curative-intent treatment options are much more limited.

Although there is no way to completely prevent pancreatic cancer, the FEAD insists that it is possible to intervene on several factors that increase the likelihood of developing it.

Smoking constitutes one of the most important modifiable risk factors, to which obesity and lack of exercise are added. For this reason, the FEAD advises not smoking, maintaining an appropriate weight through a balanced diet, and carrying out physical activity regularly.

According to the organization, these guidelines can help reduce the probability of the appearance of this tumor and, at the same time, provide health benefits overall.

"One of the main problems with this tumor is that in its initial stages it often develops without obvious symptoms. When they appear, the manifestations may be nonspecific, such as abdominal discomfort, a feeling of bloating, loss of appetite, or fatigue, and can be confused with much more common digestive problems," Ana García, an FEAD expert and a Digestive Apparatus specialist at the Hospital Universitario Ramón y Cajal in Madrid, has explained.

The FEAD indicates that, notwithstanding this, there are some signs that require medical assessment, especially when they appear in a continued manner or without a clear cause, such as unintended weight loss, abdominal pain that radiates to the back, or jaundice (yellowish discoloration of the skin and eyes).

Likewise, the recent appearance of diabetes should be monitored, especially in older people when it is accompanied by unexplained weight loss or other digestive symptoms.

From the FEAD, it is emphasized that these indications do not necessarily imply the presence of pancreatic cancer, but they do make it advisable to go to a healthcare professional to determine its origin.

Identifying people with higher risk

At present, there are no recommended pancreatic cancer screening programs for the general population. Early detection strategies are aimed above all at individuals with an especially high risk of developing the disease.

These groups include people with certain genetic mutations linked to pancreatic cancer or with significant family history, even when no specific genetic alteration has been detected.

In such situations, specialists highlight that knowing family history and consulting with healthcare professionals makes it possible to assess the advisability of genetic counseling or of specific monitoring through techniques such as magnetic resonance imaging or endoscopic ultrasound.

At the same time, research is advancing in understanding precursor lesions of pancreatic cancer and in the design of new tools, such as blood biomarkers, which could facilitate its identification in early stages, although they still require broader validation.

The FEAD reminds that, while these lines of research progress, the main available measures to contribute to prevention and promote early detection of this disease are reducing modifiable risk factors, recognizing people with a higher predisposition, and seeking medical attention when symptoms are persistent or without apparent cause.